#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

What can advanced MRI reveal about MS progression beyond relapses and new lesions? Drawing on Daniel Reich’s MSToronto2026 lecture, this article explores chronic inflammation, tolebrutinib and how imaging could help researchers identify who benefits from treatment.
#183: Silent progression in MS. Can we really detect it early?

Can silent progression in MS really be detected early? This article explains what current tests can show, where their limits are, and why noticing change is not the same as proving irreversible progression.
#172: AI-assisted MS care: How the CLAIMS project could make treatment more precise. With Prof. Friedemann Paul

How can artificial intelligence support better MS treatment decisions? Prof. Friedemann Paul explains the CLAIMS project, precision medicine, RAW and PIRA progression, and why AI should support — not replace — neurologists.
#004: Interview with Dr. Aaron Boster on the 10 red flags when to change your neurologist

Dr. Boster explains in detail the 10 red flags you shouldn’t ignore when going to your neurologist and when it is time to find a new doctor.
#002: How can a rapid and clear diagnosis be made?

Sometimes the MS diagnosis can be made quickly, but often it is much more complex and other diseases need to be clearly differentiated.